Obesity in Adolescent Men Associated With Increased Risk for Later VTE
Obesity in early adulthood is associated with increased risk for venous thromboembolism later in life, especially pulmonary embolism.
Thromboembolism
Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
Patterns of Anticoagulant Therapy Use for Acute Venous Thromboembolism
Investigators compared the use of DOACs with traditional therapies in patients with acute VTE who were either discharged directly from the ED or hospitalized.
High Incidence of Thrombotic Complications in Patients With COVID-19
Investigators assessed rates of VTE and arterial thrombotic complications in patients admitted to the ICU with COVID-19 infection.
Venous Thromboembolism vs Major Bleeding: Case Fatality Rates of Patients With Cancer Receiving Anticoagulation
Case fatality rates may vary among cancer patients with VTE or major bleeding who receive anticoagulant treatments.
Bleeding Risk Assessed With Concomitant Direct Oral Anticoagulants and Verapamil or Diltiazem
Concomitant use of dabigatran with verapamil or diltiazem was found to be associated with an increased risk of bleeding in patients with normal kidney function, according to the findings of a recently published retrospective cohort study.
Apixaban Noninferior to Dalteparin for Treatment of Cancer-Associated Venous Thromboembolism
Oral apixaban is noninferior to subcutaneous dalteparin for the treatment of cancer-linked VTE without increasing the risk of major bleeding.
Quality Improvement Effort Cuts Blood Clots in Brain Injury Patients
Prophylactic anticoagulation protocol improves patient outcomes.
Rivaroxaban Prevents VTE After Lower-Limb Surgery
Rivaroxaban superior to enoxaparin for preventing major VTE after nonmajor orthopedic surgery.
Increased Risk of Venous Thromboembolism in Patients With Myelofibrosis
One finding from this study was that VTE was more likely to occur at atypical sites in patients with myelofibrosis compared to those without the disease.
Next post in General Hematology
